NASDAQ:EYESW Second Sight Medical Products (EYESW) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.01▼$0.0550-Day Range$0.00▼$0.2252-Week Range$0.18▼$1.02Volume75,101 shsAverage Volume4,500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesTrendsStock AnalysisHeadlinesTrends Get Second Sight Medical Products alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Second Sight Medical Products Stock (NASDAQ:EYESW)Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. EYESW Stock News HeadlinesJuly 20, 2024 | msn.comSight Care Review (SCAM ALERT) Is It Safe And Beneficial For Your Eyes? Ingredients, Pros & Cons, Risks, And Honest User Reviews!May 25, 2024 | msn.comSight Review: An Uplifting True Story Tugs HeartstringsJuly 27, 2024 | The Oxford Club (Ad)Man Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.May 23, 2024 | msn.com‘Sight’ Review: Angel Studios’ Inspiring Biopic of a Chinese Immigrant Eye Surgeon Proves Sincere but BlandMay 16, 2024 | msn.comPeter Alexander's sister Rebecca started to lose her sight at 12. It was a sign of a rare diseaseMay 2, 2024 | markets.businessinsider.comEye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' AnalystMay 1, 2024 | msn.comVaping poses unexpected risks to eye health, study findsApril 30, 2024 | techcrunch.comneuroClues wants to put high speed eye tracking tech in the doctor’s officeJuly 27, 2024 | The Oxford Club (Ad)Man Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.April 29, 2024 | msn.com10 Things You Should Be Doing Today to Protect Your Eye HealthApril 26, 2024 | detroitnews.comDr. Roach: Eye drops safe to use with AMD medicationApril 23, 2024 | msn.comCrystal Clear Vision: Expert Advice for Preserving Healthy Eyes as You AgeApril 18, 2024 | msn.com'You want it to look perfect because it’s someone’s eye': Ocularists are small group and it's even tougher to get into the industryApril 17, 2024 | theguardian.com‘Pregnancy is not a disease’: why do so many women die giving birth in one of Africa’s richest countries?April 17, 2024 | msn.comMy Miscarriage Was “Common” — For Black Women That Isn’t Comforting, It’s TerrifyingApril 12, 2024 | msn.comFinally, Planned Parenthood will offer sedation for IUD insertions and removalsApril 4, 2024 | msn.comPilot in fatal hot air balloon crash in Arizona had elevated levels of ketamine in his system, report findsApril 3, 2024 | ca.style.yahoo.comThe Good Doctor Cast Exits, Ranked — Which One Hit You the Hardest?See More Headlines Receive EYESW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryN/A Current SymbolNASDAQ:EYESW CUSIPN/A CIK1266806 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key Competitors4D pharmaNASDAQ:LBPSWActinium PharmaceuticalsNYSE:ATNMAesther Healthcare AcquisitionNASDAQ:AEHAWAnzu Special Acquisition Corp INASDAQ:ANZUWBioLingus (Cayman)NASDAQ:SUBLView All Competitors This page (NASDAQ:EYESW) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Second Sight Medical Products Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Second Sight Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.